Share on StockTwits

Genocea Biosciences (NASDAQ:GNCA) major shareholder Polaris Venture Management Co. unloaded 63,794 shares of Genocea Biosciences stock on the open market in a transaction that occurred on Tuesday, August 12th. The shares were sold at an average price of $13.28, for a total value of $847,184.32. The sale was disclosed in a document filed with the Securities & Exchange Commission, which can be accessed through this link. Major shareholders that own more than 10% of a company’s stock are required to disclose their transactions with the SEC.

Genocea Biosciences (NASDAQ:GNCA) traded up 1.41% on Tuesday, hitting $12.97. 44,695 shares of the company’s stock traded hands. Genocea Biosciences has a one year low of $10.90 and a one year high of $23.99. The stock has a 50-day moving average of $16.26 and a 200-day moving average of $17.16. The company’s market cap is $225.8 million.

Genocea Biosciences (NASDAQ:GNCA) last announced its earnings results on Wednesday, August 6th. The company reported ($0.41) earnings per share for the quarter, beating the analysts’ consensus estimate of ($0.42) by $0.01. Analysts expect that Genocea Biosciences will post $-2.10 earnings per share for the current fiscal year.

Genocea Biosciences, Inc is a United States-based clinical-stage company that develops T cell vaccines.

Get Analysts' Upgrades and Downgrades via Email - Stay on top of analysts' coverage with Analyst Ratings Network's FREE daily email newsletter that provides a concise list of analysts' upgrades and downgrades. Click here to register now.